<DOC>
	<DOCNO>NCT01048203</DOCNO>
	<brief_summary>This single site , open label , single dose , non-randomized study healthy male female subject . The subject evaluate plasma , urine feces level 14C-ABR-215050 21 day .</brief_summary>
	<brief_title>A Single Dose Metabolism Mass Balance Study 14C-ABR-215050 Healthy Subjects</brief_title>
	<detailed_description>As part pharmacokinetic documentation , metabolism mass balance 14C-ABR-215050 study healthy subject . Female healthy subject include study case expand indication female form cancer . In study single dose 1.0 mg study drug administer orally solution fast condition . The absorption safety profile oral water solution also document .</detailed_description>
	<criteria>1 . 4065 year old male female subject . 2 . Healthy accord medical history , physical examination clinical chemistry , urine hematological laboratory test . 3 . Body Mass Index ( BMI ) 1830 . 4 . Negative screen Hepatitis B / C HIVinfection . 5 . Be willing able comply protocol duration study . 6 . Women childbearing potential must neither pregnant breastfeeding . Confirmation subject pregnant must establish pregnancy test single dose study end . Fertile woman must willing practice reliable method contraception . Medically accept safe method contraception purpose study include surgical sterilisation , intrauterine device , diaphragm spermicide , condom spermicide . As interaction study ABR215050 hormonal ( oral depot ) contraceptives yet perform , woman use device must also use complementary contraceptive device . 7 . Have give write sign informed consent , prior start studyrelated activity . 1 . Gastrointestinal disorder may affect drug absorption . 2 . Any vaccination within 30 day start study throughout study . 3 . Blood donation within 90 day start study 90 day study . 4 . Participation clinical study receive investigational drug within 90 day prior enrolment . Additionally , subject previously include study withdrawn study reentered study . 5 . Perform plan surgery 6 . Any use nicotine within three ( 3 ) month start study throughout study . 7 . Known suspected history alcoholism drug abuse . 8 . Intake alcoholic beverage 24 hour prior administration investigational product 24 hour dose . 9 . Intake caffeine contain beverage 10 hour prior administration investigational product 6 hour dose . 10 . Medication include herbal remedy ( vitamin paracetamol exclude ) within 14 day throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>14C ABR 215050 Metabolism Mass Balance Study</keyword>
	<keyword>tasquinimod</keyword>
	<keyword>Metabolic pattern 14C ABR-215050</keyword>
</DOC>